TrialEuropean journal of nuclear medicine and molecular imaging2019

Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.

T Konert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.